Don't be Surprised if Auryxia Doses Change Weekly

August 2015

Auryxia (aw-RIK-see-uh, ferric citrate) is another option for patients with chronic kidney disease to lower phosphate levels.

Think of it as similar to Velphoro (sucroferric oxyhydroxide).

Both are iron-based and bind phosphate in the gut...to lower phosphate levels in those who can't clear phosphate through the urine.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Patient Education Recognize When You're Receiving a 711 Call
COPD Stay Alert for Patients Switching to Stiolto From Other COPD Inhalers
Insulin Watch for Rxs Written Just as "Humalog KwikPen"
Sexually Transmitted Diseases Watch for STD Rxs That "Double Up" on Dispense Quantities
Pregnancy Expect to See Pregnancy Letter Ratings Removed from Drug Labels
Phosphate Don't be Surprised if Auryxia Doses Change Weekly
Opioids Expect to See Long-Term Buprenorphine Therapy for Opioid Dependence
Anticoagulants Consider a Calendar for Patients Using a Short-Term Blood Thinner
Prediabetes Help Spot Patients at Risk for Prediabetes
Photosensitivity Familiarize Yourself with Common Meds That Cause Sun Sensitivity
Practice Don't Automatically Substitute Between "Double-Duty" Products
Rheumatoid Arthritis Steer Patients Asking About Glucosamine or Chondroitin to the Pharmacist
Cholesterol Expect New Cholesterol Injectables to be Saved as Add-On Meds